Business Description
PELL Bio-Med Technology Co Ltd
ISIN : TW0006949001
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.88 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.45 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 7.6 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.76 | |||||
9-Day RSI | 32.45 | |||||
14-Day RSI | 31.13 | |||||
6-1 Month Momentum % | 21.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.21 | |||||
Quick Ratio | 7.19 | |||||
Cash Ratio | 7.1 | |||||
Days Inventory | 34.64 | |||||
Days Sales Outstanding | 107.81 | |||||
Days Payable | 67.82 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -19.68 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -113.23 | |||||
Operating Margin % | -2360.14 | |||||
Net Margin % | -2237.69 | |||||
FCF Margin % | -1096.97 | |||||
ROE % | -35.03 | |||||
ROA % | -27.94 | |||||
ROIC % | -127.91 | |||||
ROC (Joel Greenblatt) % | -144.79 | |||||
ROCE % | -30.44 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 1.77 | |||||
PS Ratio | 48.27 | |||||
PB Ratio | 3.4 | |||||
Price-to-Tangible-Book | 3.41 | |||||
EV-to-EBIT | -8.28 | |||||
EV-to-EBITDA | -9.35 | |||||
EV-to-Revenue | 186.34 | |||||
EV-to-FCF | -17.04 | |||||
Price-to-Graham-Number | 0.52 | |||||
Price-to-Net-Current-Asset-Value | 4.61 | |||||
Price-to-Net-Cash | 4.72 | |||||
Earnings Yield (Greenblatt) % | -12.07 | |||||
FCF Yield % | -4.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PELL Bio-Med Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 17.989 | ||
EPS (TTM) (NT$) | -42.518 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 31.13 | ||
14-Day ATR (NT$) | 2.778886 | ||
20-Day SMA (NT$) | 84.685 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (NT$) | 70.6 - 178.5 | ||
Shares Outstanding (Mil) | 57.12 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PELL Bio-Med Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PELL Bio-Med Technology Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
PELL Bio-Med Technology Co Ltd Frequently Asked Questions
What is PELL Bio-Med Technology Co Ltd(TPE:6949)'s stock price today?
When is next earnings date of PELL Bio-Med Technology Co Ltd(TPE:6949)?
Does PELL Bio-Med Technology Co Ltd(TPE:6949) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |